Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and Provides Business Update

$36.9 million in cash and cash equivalents as of December 31, 2022 ; runway through February 2024 Uptick in patient recruitment for Mino-Lok® Phase 3 trial Halo-Lido Phase 2b trial nearing completion CRANFORD,...

Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.

Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion) and there...

Adding ATAI (ATAI) to 2024 Watch List. Doubling Down at $1.80, After Anti Depression...

Both a bad day and a Good day for Psychedelics. The Psychedelic Sector Holds Firm. Atai was founded in 2018 and went public in June...

Ouch, for Now. Progressive Care Does 200:1 Reverse.

MASSIVE REVERSE SPLIT Let's just watch from the sidelines for now. If you had 100,000 shares last Friday, you now own 500 shares. Opened at...

He Shoots And He Scores. Ardelyx (ARDX) Gains 78%. Happy New Year!

Ah yes, and Gains Come to the Patient, as the FDA Moves the Ardelyx Ball Further Along. Despite the 78% gain since November 17th, the...
SILO Pharmaceutical, Psychedelic Stock Review

Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis

SPU-21 effective in controlling arthritis progression. SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide ENGLEWOOD CLIFFS, NJ, Dec. 30, 2022 (GLOBE...

Ardelyx (ARDX). Don’t be Nervous, It’s Just Money.

The Higher it Goes, The More Nervous we Get. LIVE QUOTE Not much to report here, other then there could be news any day, any week....

FDA to Ardelyx: “Give us a Couple More Weeks.” (ARDX) $1.80.

Oh boy, another day, another snag. There goes our Christmas bonus, dang. LIVE QUOTE It's been a gut wrenching couple years for shareholders. Is it big...

Can Lightning Strike Twice? Mitesco (MITI, MITID) Health Clinics.

Mitesco one of our Past Clients, Gained 10-Fold After we Added it to the Watch List, Just did a Reverse Split in an Effort...

Adding Unicycive (UNCY) $0.75 to the Watch List.

Similar to Ardlyx (ARDX) which we added to the Watch List last week, Unicycive (no we don't know how they pronounce it) which will call UNCY - is a biotech...

Latest article

Annette L. Redmond Joins Strategic Advisory Board at Sekur Private Data (SWISF).

Former U.S. State Department Deputy Assistant Secretary Decorated intelligence and cybersecurity executive with four decades of U.S. government leadership joins Sekur to advise on secure...

10X Alerts: Sekur Private Data (SWISF) Pushes SekurOne Closer to Market With First International...

Sekur has completed its first domestic and international encrypted calls on SekurOne and launched the platform’s voice, email, messenger, and VPN capabilities on Android...

Could a Record El Niño Ignite the Next Vaccine Trade?

Chikungunya, Dengue Fever, Rift Valley Fever and Zika The Coming El Niño: An Overlooked Catalyst for Vaccine Stocks? Investors obsess over interest rates, tariffs and AI....